News
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc.
11h
TipRanks on MSNEli Lilly completes acquisition of Verve TherapeuticsEli Lilly and Company (LLY) announced the successful completion of its acquisition of Verve Therapeutics. (VERV). Verve is a Boston-based clinical-stage company developing genetic medicines for ...
Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to ...
CRISPR Therapeutics AG stock has soared 90% since May, driven by Casgevy approval and future breakthroughs in gene editing.
Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru cofounded Verve Therapeutics, a company developing a therapy that uses ...
4d
MarketBeat on MSN3 Bullish Biotech Stocks With Explosive Growth TrendsInvesting in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results